Sara M. Haserlat

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al. · New England Journal of Medicine · 2004 · 11.5K citations

Medicine, Oncology, Pharmacology +16

Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials

Daphne W. Bell, Thomas J. Lynch, Sara M. Haserlat et al. · Journal of Clinical Oncology · 2005 · 607 citations

Medicine, Molecular Genetics, Oncology +17

Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas

Eunice L. Kwak, Janusz Jankowski, Sarah P. Thayer et al. · Clinical Cancer Research · 2006 · 158 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of<i>ERBB2</i>rather than<i>EGFR</i>

Ezra E.W. Cohen, Mark W. Lingen, Leslie E. Martin et al. · Clinical Cancer Research · 2005 · 129 citations

Medicine, Oncology, Pharmacology +15

Genetic and functional analysis of <i>CHEK2</i> (<i>CHK2</i>) variants in multiethnic cohorts

Daphne W. Bell, Sang Ho Kim, Andrew K. Godwin et al. · International Journal of Cancer · 2007 · 91 citations · Full text

Medicine, Genetics, Molecular Genetics +17